#compounded-drugs

[ follow ]
#fda-regulation #semaglutide #glp-1 #telehealth #novo-nordisk #fda #social-media-influencers #drug-pricing
Medicine
fromBusiness Insider
1 week ago

Hims & Hers removes a knock-off weight loss drug days after introducing it

Hims & Hers launched, then halted, a compounded once-daily semaglutide pill after the FDA moved to restrict mass-marketed, unapproved compounded GLP-1 drug sales.
Business
fromFuturism
1 week ago

Novo Nordisk Furious at $49 Knockoff Ozempic Pill

Novo Nordisk is pursuing legal and regulatory action against Hims & Hers over a low-cost compounded Wegovy knockoff, prompting FDA scrutiny and volatile stock moves.
Public health
fromBloomberglaw
4 months ago

FDA's Deceptive Drug Ad Focus Leaves Telehealth Sites Guessing

FDA is cracking down on deceptive drug ads but authority to regulate influencer promotions of compounded drugs by telehealth companies remains unclear.
Public health
fromBusiness Insider
4 months ago

Online pharmacies are still selling cheap copycat Ozempic and other weight loss drugs, despite new FDA rules

Cheaper compounded GLP-1 copycats remain widely used despite resolved shortages, FDA warnings, and legal threats, driven by high branded prices and strong patient demand.
fromMedpagetoday
5 months ago

FDA Takes Aim at Hims & Hers, Weight-Loss Drugs in New Advertising Blitz

"the same active ingredient"
Public health
fromBloomberglaw
5 months ago

FDA Chief Says Hims' Weight-Loss Drug Ad Breached Agency's Rules

"Online pharmacies are advertising drugs with only upsides mentioned, contributing to America's culture of overreliance on pharmaceuticals for health," Makary wrote in a JAMA Network Open article focused on how the agency is overdue for a "crackdown on misleading pharmaceutical advertisements."
Public health
[ Load more ]